Box containing 30 controlled release capsules.
Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).
Reducing the risk of acute urinary retention
Each controlled release capsule contains: Dutasteride 0.50 mg/Tamsulosin hydrochloride 0.40 mg
BALIARDA